Ana Claudia Oliveira Carreira

Prof. Dr. Ana Claudia Oliveira Carreira

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2017 in Nanoscale
Verified
Journal Article
Open access
PDF file
MRMarcel I. Ramirez
Marcel I. Ramirez
MAMaria G. Amorim
Maria G. Amorim
CGCatarina Gadelha
Catarina Gadelha
IMIvana Milic
Ivana Milic
Joshua WelshJoshua Welsh
Joshua Welsh
EDEmmanuel Dias-Neto
Emmanuel Dias-Neto
Extracellular Vesicles (EVs) are gaining interest as central players in liquid biopsies, with potential applications in diagnosis, prognosis and therapeutic guidance in most pathological conditions.

3 January 2014 in Journal of Dental Research
Verified
Journal Article
Closed access
ACAna Claudia Oliveira Carreira
Ana Claudia Oliveira Carreira
FLF.H. Lojudice
F.H. Lojudice
EHE. Halcsik
E. Halcsik
RNR.D. Navarro
R.D. Navarro
MSMari Sogayar
Mari Sogayar
JGJose M. Granjeiro
Jose M. Granjeiro
Bone morphogenetic proteins (BMPs) are members of the TGF-β superfamily, acting as potent regulators during embryogenesis and bone and cartilage formation and repair. Cell and molecular biology approaches have unveiled the great complexity of BMP action, later confirmed by transgenic animal studies. Genetic engineering allows for the production of large amounts of BMPs for clinical use, but they have systematically been associated with a delivery system, such as type I collagen and calcium phosphate ceramics, to ensure controlled release and to maximize their biological activity at the surgical site, avoiding systemic diffusion. Clinical orthopedic studies have shown the benefits of FDA-approved recombinant human BMPs (rhBMPs) 2 and 7, but side effects, such as swelling, seroma, and increased cancer risk, have been reported, probably due to high BMP dosage. Several studies have supported the use of BMPs in periodontal regeneration, sinus lift bone-grafting, and non-unions in oral surgery. However, the clinical use of BMPs is growing mainly in off-label applications, with robust evidence to ascertain rhBMPs’ safety and efficacy through well-designed, randomized, and double-blind clinical trials. Here we review and discuss the critical data on BMP structure, mechanisms of action, and possible clinical applications.

1 November 2014 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
ACAna Claudia Oliveira Carreira
Ana Claudia Oliveira Carreira
GAGutemberg Alves
Gutemberg Alves
Willian Fernando ZambuzziWillian Fernando Zambuzzi
Willian Fernando Zambuzzi
MSMari Sogayar
Mari Sogayar
JGJose M. Granjeiro
Jose M. Granjeiro

29 May 2015 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
GDGildasio Cerqueira Daltro
Gildasio Cerqueira Daltro
VFVitor Fortuna
Vitor Fortuna
ESEliane Silva de Souza
Eliane Silva de Souza
MSMarcela Miranda Salles
Marcela Miranda Salles
ACAna Claudia Oliveira Carreira
Ana Claudia Oliveira Carreira
RBRadovan Borojevic
Radovan Borojevic
Introduction: Stem cell therapy with bone marrow-derived mononuclear cells (BMMCs) is an option for improving joint function in osteonecrosis of the femoral head (ONFH). Bone marrow-derived mesenchymal stromal cell (MSC) numbers and their osteogenic differentiation are decreased in patients with ONFH. However, whether this decrease also extends to the early stages of ONFH in sickle cell disease (SCD) is still unclear. Methods: We conducted a phase I/II, non-controlled study to determine efficacy and safety of BMMC implantation using a minimally invasive technique in SCD patients with ONFH. Eighty-nine patients were recruited and followed up for 60 months after surgery. Clinical and radiographic findings were assessed, and data were completed by in vitro analysis. Results: At the final follow-up (60 months) there was a significant improvement in clinical joint symptoms and pain relief as measured by the Harris Hip Score (P = 0.0005). In addition, after the BMMC implantation procedure, radiographic assessment showed disease stabilization and only 3.7 % of the treated patients did not achieve a satisfactory clinical result. The amount of fibroblast colony-forming units was 28.2 ± 13.9 per 1 million BMMCs after concentration. Flow cytometry analysis showed a significantly higher number of hematopoietic stem/endothelial progenitor cell markers in concentrated BMMCs when compared with bone marrow aspirate, indicating an enrichment of these cell types. Isolated MSCs from SCD patients with pre-collapse ONFH maintained the replicative capacity without significant loss of their specific biomolecular characteristics, multi-differentiation potential, and osteogenic differentiation activities. Cytokines and growth factors (interleukin-8, transforming growth factor-beta, stromal cell-derived factor-1alpha and vascular endothelial growth factor) that mediate endogenous bone regeneration were also produced by expanded MSCs from SCD patients. Conclusion: The autologous BMMC implantation with a minimally invasive technique resulted in significant pain relief and halted the progression of early stages of ONFH in SCD patients. MSCs from SCD patients display biological properties that may add to the efficiency of surgical treatment in ONFH. In summary, our results indicate that infusion of BMMCs enriched with stem/progenitor cells is a safe and effective treatment for the early stages of ONFH in SCD patients. Trial registration: ClinicalTrials.gov NCT02448121; registered 15 May 2015.

1 January 2015 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
MAMateus C Adolfi
Mateus C Adolfi
ACAna Claudia Oliveira Carreira
Ana Claudia Oliveira Carreira
LJLázaro Wo Jesus
Lázaro Wo Jesus
JBJan Bogerd
Jan Bogerd
RFRejane M Funes
Rejane M Funes
MBMaria I Borella
Maria I Borella
The dmrt1 and sox9 genes have a well conserved function related to testis formation in vertebrates, and the group of fish presents a great diversity of species and reproductive mechanisms. The lambari fish (Astyanax altiparanae) is an important Neotropical species, where studies on molecular level of sex determination and gonad maturation are scarce. Here, we employed molecular cloning techniques to analyze the cDNA sequences of the dmrt1 and sox9 genes, and describe the expression pattern of those genes during development and the male reproductive cycle by qRT-PCR, and related to histology of the gonad. Phylogenetic analyses of predicted amino acid sequences of dmrt1 and sox9 clustered A. altiparanae in the Ostariophysi group, which is consistent with the morphological phylogeny of this species. Studies of the gonad development revealed that ovary formation occurred at 58 days after hatching (dah), 2 weeks earlier than testis formation. Expression studies of sox9 and dmrt1 in different tissues of adult males and females and during development revealed specific expression in the testis, indicating that both genes also have a male-specific role in the adult. During the period of gonad sex differentiation, dmrt1 seems to have a more significant role than sox9. During the male reproductive cycle dmrt1 and sox9 are down-regulated after spermiation, indicating a role of these genes in spermatogenesis. For the first time the dmrt1 and sox9 were cloned in a Characiformes species. We show that both genes have a conserved structure and expression, evidencing their role in sex determination, sex differentiation and the male reproductive cycle in A. altiparanae. These findings contribute to a better understanding of the molecular mechanisms of sex determination and differentiation in fish.

1 January 2015
Verified
Book Chapter
Closed access
ACAna Claudia Oliveira Carreira
Ana Claudia Oliveira Carreira
Willian Fernando ZambuzziWillian Fernando Zambuzzi
Willian Fernando Zambuzzi
MRMariana Rossi
Mariana Rossi
RFRenato Astorino Filho
Renato Astorino Filho
MSMari Sogayar
Mari Sogayar
JGJose M. Granjeiro
Jose M. Granjeiro